Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.

Braganca Xavier C, Andersen CR, Lim J, Slade JH, Bean SA, Kang L, Le H, Tsimberidou AM, Naing A, Hong DS, Dumbrava EE, Rodon Ahnert J, Pohlmann PR, Piha-Paul SA, Champiat S, Yap TA, Tang TY, Meric-Bernstam F, Fu S

Open source

DOI: 10.1158/2767-9764.crc-25-0033
Published: 2025 Sep 1
Container: Cancer research communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-25-0033,
  title = {Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.},
  author = {Braganca Xavier C and Andersen CR and Lim J and Slade JH and Bean SA and Kang L and Le H and Tsimberidou AM and Naing A and Hong DS and Dumbrava EE and Rodon Ahnert J and Pohlmann PR and Piha-Paul SA and Champiat S and Yap TA and Tang TY and Meric-Bernstam F and Fu S},
  year = {2025},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-25-0033},
  url = {https://doi.org/10.1158/2767-9764.crc-25-0033}
}

RIS

TY  - JOUR
TI  - Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.
AU  - Braganca Xavier C
AU  - Andersen CR
AU  - Lim J
AU  - Slade JH
AU  - Bean SA
AU  - Kang L
AU  - Le H
AU  - Tsimberidou AM
AU  - Naing A
AU  - Hong DS
AU  - Dumbrava EE
AU  - Rodon Ahnert J
AU  - Pohlmann PR
AU  - Piha-Paul SA
AU  - Champiat S
AU  - Yap TA
AU  - Tang TY
AU  - Meric-Bernstam F
AU  - Fu S
PY  - 2025
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-25-0033
UR  - https://doi.org/10.1158/2767-9764.crc-25-0033
ER  -

APA

C, B. X., CR, A., J, L., JH, S., SA, B., L, K., H, L., AM, T., A, N., DS, H., EE, D., J, R. A., PR, P., SA, P., S, C., TA, Y., TY, T., F, M., & S, F. (2025). Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-25-0033

Source records

pubmed · retrieved 2026-09-27T08:17:07.740Z